JOHN JOHNSON: Open Payments
NPI 1174180624 · NEW CASTLE, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 6 payments from 4 companies in 2025. Trend: 2023 $20 · 2024 $219 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $151 |
| E.R. Squibb & Sons, L.L.C. | 1 | $118 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Alkermes, Inc. | 1 | $28 |
Products named: INGREZZA, COBENFY, FANAPT, ARISTADA.
Industry payments across DE — which companies pay providers there.
